Vivus, Inc.
Vivus, Inc. appears in FDA public data with 1 recall, 2 510(k) clearances, 5 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0896-2023, Class III) was initiated on June 23, 2023. Its most recent 510(k) clearance was granted on December 19, 2000.
Summary
- Total Recalls
- 1
- 510(k) Clearances
- 2
- Inspections
- 5
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0896-2023 | Class III | PANCREAZE (pancrelipase) Delayed-Release Capsules, 100-count bottles, Rx only, Rx only, Manufactured | June 23, 2023 |